Diamond Biotechnology Co (ROCO:6815) Market Cap: NT$1,172.9 Mil (As of Jul. 18, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6815 Diamond Biotechnology Co Ltd ROCO:6815
80 GF Score
Price NT$29.70
GF Value NT$48.10
Valuation Possible Value Trap
! 7 Warning Signs
View Full Analysis

What is Diamond Biotechnology Co Market Cap?

Diamond Biotechnology Co ROCO:6815 +3.85% 80 Market Cap is NT$1,172.9 Mil as of Jul. 18, 2026. GuruFocus rates ROCO:6815 with a GF Score™ of 80/100 and a GF Value™ of NT$48.10 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 866 Medical Devices & Instruments companies, Diamond Biotechnology Co ranks worse than 67.67% on this metric.

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Diamond Biotechnology Co's share price for the quarter that ended in Dec. 2025 was NT$62. Diamond Biotechnology Co's Shares Outstanding (EOP) for the quarter that ended in Dec. 2025 was 39.5 Mil. Therefore, Diamond Biotechnology Co's market cap for the quarter that ended in Dec. 2025 was NT$2,448.6 Mil.

Diamond Biotechnology Co's quarterly market cap declined from Dec. 2024 (NT$2,616.4 Mil) to Jun. 2025 (NT$1,847.0 Mil) but then increased from Jun. 2025 (NT$1,847.0 Mil) to Dec. 2025 (NT$2,448.6 Mil).

Diamond Biotechnology Co's annual market cap increased from Dec. 2023 (NT$2,415.9 Mil) to Dec. 2024 (NT$2,616.4 Mil) but then declined from Dec. 2024 (NT$2,616.4 Mil) to Dec. 2025 (NT$2,448.6 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Diamond Biotechnology Co's Enterprise Value for Today is NT$1,197.0 Mil.


Diamond Biotechnology Co  (ROCO:6815) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Diamond Biotechnology Co Market Cap Related Terms


Diamond Biotechnology Co Market Cap Historical Data

* Premium members only.

The historical data trend for Diamond Biotechnology Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Diamond Biotechnology Co Market Cap Chart

Diamond Biotechnology Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Market Cap
Get a 7-Day Free Trial Premium Member Only 975.39 864.86 2,415.89 2,616.38 2,448.57

Diamond Biotechnology Co Semi-Annual Data
Dec17 Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 2,415.89 2,960.32 2,616.38 1,847.01 2,448.57

ROCO:6815 vs ABT, SYK, MDT: Market Cap Comparison

For the Medical Devices subindustry, Diamond Biotechnology Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Diamond Biotechnology Co Market Cap vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Diamond Biotechnology Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Diamond Biotechnology Co's Market Cap falls into.


ROCO:6815
80GF Score
Diamond Biotechnology Co Ltd ROCO:6815
Market Cap is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Diamond Biotechnology Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Diamond Biotechnology Co's Market Cap for the fiscal year that ended in Dec. 2025 is calculated as

Market Cap (A: Dec. 2025 )=Share Price (A: Dec. 2025 )*Shares Outstanding (EOP) (A: Dec. 2025 )
=NT$62*39.493
=NT$2,448.6

Diamond Biotechnology Co's Market Cap for the quarter that ended in Dec. 2025 is calculated as

Market Cap (Q: Dec. 2025 )=Share Price (Q: Dec. 2025 )*Shares Outstanding (EOP) (Q: Dec. 2025 )
=NT$62*39.493
=NT$2,448.6

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about Market Cap →
What does a Market Cap of NT$1,172.9 Mil mean?
Diamond Biotechnology Co (ROCO:6815) has a Market Cap of NT$1,172.9 Mil as of Jul. 18, 2026. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Diamond Biotechnology Co and its competitors. According to the industry distribution chart, Diamond Biotechnology Co ranks #586 out of 866 companies in the Medical Devices & Instruments industry, placing it in the top 67.7%.
Is Diamond Biotechnology Co's Market Cap too high?
Diamond Biotechnology Co's current Market Cap is NT$1,172.9 Mil. Based on the distribution chart, Diamond Biotechnology Co ranks #586 out of 866 companies in the Medical Devices & Instruments industry, which is below the industry midpoint. Overall, Diamond Biotechnology Co has a GF Score™ of 80/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Diamond Biotechnology Co's Market Cap compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Diamond Biotechnology Co ranks #586 out of 866 companies for Market Cap. This places Diamond Biotechnology Co in the lower half of its industry. The industry median Market Cap is 115.63. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Market Cap for a Medical Devices & Instruments company?
The median Market Cap among Medical Devices & Instruments companies is 115.63, based on 866 companies in the industry. Companies in the top quartile (top 25%) have a Market Cap significantly above this median, while those in the bottom quartile fall well below. However, Market Cap should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Market Cap mean?
A high Market Cap can signal that a stock is expensive relative to its fundamentals. Market cap equals the total value of a company's shares: price times shares outstanding. View historical data on Diamond Biotechnology Co and its competitors. For the Medical Devices & Instruments industry, the median Market Cap is 115.63 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Diamond Biotechnology Co's current Market Cap is NT$1,172.9 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Diamond Biotechnology Co stock overvalued right now?
Based on GuruFocus' analysis, Diamond Biotechnology Co (ROCO:6815) is currently considered Possible Value Trap. The stock's GF Value™ is NT$48.10, compared to a current price of NT$29.70 — trading 38.3% below its estimated fair value. The current Market Cap is NT$1,172.9 Mil. Diamond Biotechnology Co's overall GF Score™ is 80/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Market Cap calculated?
Market Cap is calculated from a company's financial statements. For Diamond Biotechnology Co (ROCO:6815), the current Market Cap is NT$1,172.9 Mil as of Jul. 18, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Diamond Biotechnology Co (ROCO:6815) Overvalued in 2026?

Based on GuruFocus' analysis, Diamond Biotechnology Co stock appears to be undervalued. The current stock price of NT$29.70 is trading 38.3% below its estimated GF Value™ of NT$48.10. GuruFocus considers Diamond Biotechnology Co to be Possible Value Trap.

Key valuation signals for ROCO:6815:

  • Market Cap: NT$1,172.9 Mil
  • GF Value™: NT$48.10 vs. price of NT$29.70 (38.3% below fair value)
  • GF Score™: 80/100 with 7 warning signs

No single metric tells the full story. See the ROCO:6815 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Diamond Biotechnology Co Business Description

Address No. 45, Section 2, Fuxing South Road, Da'an District, 11th Floor, Taipei, TWN
Diamond Biotechnology Co Ltd is engaged in the research and development of medical equipment, and medical consumables. It also manufactures and sells medical beauty-level skincare products.
80GF Score

Get the complete analysis for ROCO:6815

Market Cap is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$29.70
Price
NT$48.10
GF Value